Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| Revenues | 71.2 | 3.0 | 0.5 | 1.9 | 2.5 | 3.0 | 2.3 | 0.0 |
| Revenue growth | 2301.6% | 501.4% | -73.4% | -26.2% | -15.8% | 27.2% | | -100.0% |
| Cost of goods sold | 27.4 | 1.4 | 0.1 | 0.0 | 0.7 | 1.9 | 1.1 | -0.1 |
| Gross profit | 43.8 | 1.6 | 0.4 | 1.9 | 1.8 | 1.0 | 1.3 | 0.1 |
| Gross margin | 61.5% | 54.3% | 85.2% | 100.0% | 70.5% | 34.6% | 54.2% | |
| Sales and marketing | 7.0 | 6.5 | 0.8 | | | | | |
| Research and development | | | | | | | | |
| General and administrative | 15.9 | 12.5 | 20.4 | 9.5 | 8.4 | 13.9 | 13.4 | 2.1 |
| EBIT | 20.9 | -17.3 | -20.8 | -7.6 | -6.6 | -12.8 | -12.1 | -7.4 |
| EBIT margin | 29.4% | -584.7% | -4218.1% | -410.5% | -262.8% | -430.9% | -519.0% | |
| Pre-tax income | 22.3 | -15.2 | -13.3 | 3.9 | -9.5 | -13.2 | -25.6 | 17.8 |
| Income taxes | 6.6 | -2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 29.5% | 13.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Earnings from continuing ops | 15.7 | -13.2 | -13.3 | 3.9 | -9.5 | -13.2 | -25.6 | 5.3 |
| Earnings from discontinued ops | | | | -0.7 | -0.6 | -0.6 | -20.2 | -5.0 |
| Net income | 15.7 | -13.2 | -13.3 | 3.9 | -9.5 | -13.2 | -25.6 | 0.3 |
| Net margin | 22.0% | -444.9% | -2688.4% | 213.1% | -380.1% | -441.8% | -1093.0% | |
| |
| Diluted EPS | $0.40 | ($0.34) | ($0.35) | $0.11 | ($0.26) | ($0.32) | ($0.58) | $0.12 |
| Shares outstanding (diluted) | 39.0 | 38.3 | 37.8 | 37.5 | 36.7 | 40.5 | 44.4 | 45.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|